Short and Long-Term Effects of the Angiotensin II Receptor Blocker Irbesartan on Intradialytic Central Hemodynamics: A Randomized Double-Blind Placebo-Controlled One-Year Intervention Trial (the SAFIR Study)

BACKGROUND AND AIM: Little is known about the tolerability of antihypertensive drugs during hemodialysis treatment. The present study evaluated the use of the angiotensin II receptor blocker (ARB) irbesartan. DESIGN: Randomized, double-blind, placebo-controlled, one-year intervention trial. SETTING...

Descripción completa

Detalles Bibliográficos
Autores principales: Peters, Christian Daugaard, Kjaergaard, Krista Dybtved, Jensen, Jens Dam, Christensen, Kent Lodberg, Strandhave, Charlotte, Tietze, Ida Noerager, Novosel, Marija Kristina, Bibby, Bo Martin, Jespersen, Bente
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452642/
https://www.ncbi.nlm.nih.gov/pubmed/26030651
http://dx.doi.org/10.1371/journal.pone.0126882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452642/
https://www.ncbi.nlm.nih.gov/pubmed/26030651
http://dx.doi.org/10.1371/journal.pone.0126882

Ejemplares similares